ADMA BIOLOGICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Adma Biologics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Adma Biologics, Inc. Return On Assets for the quarter ending September 30, 2024 was 18.8 %.
  • Adma Biologics, Inc. annual Return On Assets for 2023 was -8.29 %, a 60.6% increase from 2022.
  • Adma Biologics, Inc. annual Return On Assets for 2022 was -21 %, a 27.9% increase from 2021.
  • Adma Biologics, Inc. annual Return On Assets for 2021 was -29.1 %, a 23.1% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 18.8 +25.4 Jul 1, 2024 Sep 30, 2024
Q2 2024 9.9 +22 Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.06 +13.8 +92.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -8.29 +12.7 +60.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -6.61 +17.2 +72.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -12.1 +14 +53.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -14.8 +14.8 +50% Jan 1, 2023 Mar 31, 2023
Q4 2022 -21 +8.12 +27.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -23.8 +8.73 +26.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -26.1 +7.87 +23.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -29.7 +6.66 +18.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.1 +8.74 +23.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.5 +4.68 +12.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -34 +2.84 +7.71% Apr 1, 2021 Jun 30, 2021
Q1 2021 -36.3 -1.1 -3.12% Jan 1, 2021 Mar 31, 2021
Q4 2020 -37.9 +1.83 +4.61% Oct 1, 2020 Dec 31, 2020
Q3 2020 -37.2 +12.6 +25.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -36.8 +20.2 +35.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -35.2 +27.2 +43.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -39.7 +25.4 +39% Oct 1, 2019 Dec 31, 2019
Q3 2019 -49.8 +7.58 +13.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -57.1 +5.28 +8.47% Apr 1, 2019 Jun 30, 2019
Q1 2019 -62.4 -0.64 -1.04% Jan 1, 2019 Mar 31, 2019
Q4 2018 -65.1 -3.24 -5.24% Oct 1, 2018 Dec 31, 2018
Q3 2018 -57.4 +13.8 +19.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -62.4 +1.43 +2.24% Apr 1, 2018 Jun 30, 2018
Q1 2018 -61.7 +23.6 +27.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -61.8 +14.2 +18.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -71.1 +5.03 +6.61% Jul 1, 2017 Sep 30, 2017
Q2 2017 -63.8 +15.1 +19.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -85.3 -10.2 -13.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -76.1 -13.7 -22% Oct 1, 2016 Dec 31, 2016
Q3 2016 -76.2 -19 -33.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -78.9 -26.4 -50.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -75.1 -24.3 -47.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -62.4 -2.39 -3.99% Oct 1, 2015 Dec 31, 2015
Q3 2015 -57.2 +4.14 +6.75% Jul 1, 2015 Sep 30, 2015
Q2 2015 -52.5 +16.2 +23.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -50.9 +36.4 +41.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 -60 +35.3 +37.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -61.3 +46 +42.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -68.7 +33.7 +32.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -87.3 -19.3 -28.4% Jan 1, 2014 Mar 31, 2014
Q4 2013 -95.3 -47.9 -101% Oct 1, 2013 Dec 31, 2013
Q3 2013 -107 +1.84 +1.69% Jul 1, 2013 Sep 30, 2013
Q2 2013 -102 +21.7 +17.5% Apr 1, 2013 Jun 30, 2013
Q1 2013 -68 +178 +72.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -47.4 Oct 1, 2012 Dec 31, 2012
Q3 2012 -109 Jul 1, 2012 Sep 30, 2012
Q2 2012 -124 Apr 1, 2012 Jun 30, 2012
Q1 2012 -247 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.